C 21 H 22 N 2 O4, monoclinic, P21/n (no. 14), a = 8.1261(14) Å,
in ethanol (100 mL) was refluxed for 2-3 h and then cooled to room temperature. After filtering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum.
Experimental details
H atoms bonded to C and N atoms were positioned geometrically and refined using a riding model, with C-H = 0.96 Å and N-H = 0.86 Å with U iso (H) = 1.2 times Ueq(C) and 1.2 times Ueq(N).
Comment
Many people experience a skin disease at some point in their lives, since the skin is the body's largest organ and it is rather exposed, greatly increasing its risk of becoming diseased or damaged. Pyran derivatives possess several types of pharmacological properties such as anticancer, anti-HIV, anticoagulant, spasmolytic, and antibacterial activity [1] [2] [3] [4] [5] . A large number of structurally novel pyran have been used to treat most forms of skin diseases, typically combined into a multi-drug chemotherapy regimen. Considering their importance, research focused on the synthesis of new pyran derivatives [6] .
In the crystal structure of the title compound, the 4H-pyran ring is connected with the adjacent cyclohexenone ring. The C-C, C-N and C-O bond lengths are all in their normal ranges. The bond distances and angles in the title compound are comparable with the known compound C 20 H 23 NO4 [8] . In the title compound, one -CN group bonded to the carbon atom (C19) which may produce a different functionality related to the unsubstituted comparable molecules.
